Page last updated: 2024-11-12

schweinfurthin f

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

schweinfurthin F: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

schweinfurthin F : A stilbenoid isolated from Macaranga alnifolia and has been shown to exhibit cytotoxic activity. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
MacarangagenusA plant genus. Members contain mappain.[MeSH]EuphorbiaceaeThe spurge family of flowering plants in the order Malpighiales. The family consists of annual and perennial herbs and woody shrubs or trees. Members contain securinine.[MeSH]
Macaranga alnifoliaspecies[no description available]EuphorbiaceaeThe spurge family of flowering plants in the order Malpighiales. The family consists of annual and perennial herbs and woody shrubs or trees. Members contain securinine.[MeSH]

Cross-References

ID SourceID
PubMed CID16721018
CHEMBL ID376007
CHEBI ID66436
SCHEMBL ID24867153
MeSH IDM0508634

Synonyms (7)

Synonym
schweinfurthin f
chebi:66436 ,
CHEMBL376007
5-{(e)-2-[(2r,4ar,9ar)-2-hydroxy-5-methoxy-1,1,4a-trimethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-7-yl]ethenyl}-2-(3-methylbut-2-en-1-yl)benzene-1,3-diol
Q27134997
5-[(e)-2-[(7r,8ar,10ar)-7-hydroxy-4-methoxy-8,8,10a-trimethyl-6,7,8a,9-tetrahydro-5h-xanthen-2-yl]ethenyl]-2-(3-methylbut-2-enyl)benzene-1,3-diol
SCHEMBL24867153
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
cyclic etherAny ether in which the oxygen atom forms part of a ring.
organic heterotricyclic compoundAn organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.
resorcinolsAny benzenediol in which the two hydroxy groups are meta to one another.
stilbenoidAny olefinic compound characterised by a 1,2-diphenylethylene backbone.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID293632Inhibition of DNA synthesis in human RPMI cells by [3H]-thymidine incorporation assay2007Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
Total synthesis of (R,R,R)- and (S,S,S)-schweinfurthin F: differences of bioactivity in the enantiomeric series.
AID527730Cytotoxicity against human NCI60 cells2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Biologically active biotin derivatives of schweinfurthin F.
AID293635Growth inhibition of U251 cells2007Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
Total synthesis of (R,R,R)- and (S,S,S)-schweinfurthin F: differences of bioactivity in the enantiomeric series.
AID280644Antiproliferative activity against drug-sensitive human A2780 cells2007Journal of natural products, Mar, Volume: 70, Issue:3
Antiproliferative prenylated stilbenes and flavonoids from Macaranga alnifolia from the Madagascar rainforest.
AID293633Growth inhibition of NCI60 cells after 48 hrs2007Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
Total synthesis of (R,R,R)- and (S,S,S)-schweinfurthin F: differences of bioactivity in the enantiomeric series.
AID293636Growth inhibition of HS578T cells2007Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
Total synthesis of (R,R,R)- and (S,S,S)-schweinfurthin F: differences of bioactivity in the enantiomeric series.
AID293634Growth inhibition of SNB75 cells2007Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
Total synthesis of (R,R,R)- and (S,S,S)-schweinfurthin F: differences of bioactivity in the enantiomeric series.
AID1502930Antiproliferative activity against human A549 cells after 72 hrs by MTS assay2017Journal of natural products, 10-27, Volume: 80, Issue:10
Cytotoxic Prenylated Stilbenes Isolated from Macaranga tanarius.
AID1502929Antiproliferative activity against human U87 cells after 72 hrs by MTS assay2017Journal of natural products, 10-27, Volume: 80, Issue:10
Cytotoxic Prenylated Stilbenes Isolated from Macaranga tanarius.
AID1125712Cytotoxicity against human SF295 cells2014Bioorganic & medicinal chemistry, Apr-15, Volume: 22, Issue:8
Synthesis and structure activity relationships of schweinfurthin indoles.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's6 (60.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.10 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.49 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]